Power Law company profile

I-Mab Biopharma

Biotech & Life Sciences · Huangpu, China · Founded 2016 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$272M

Market cap · 2026

Investors

20 investors on I-Mab Biopharma's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Cambridge Capital

CBC Group

Series B+ 18 investors entered at this stage

Octagon Capital Partners

Sphera Global Healthcare Fund

Global footprint

Where I-Mab Biopharma has talent and traffic

Web traffic by country

130 monthly visits
across markets

🇺🇸 United States76.9%

Top 1 markets shown

Patent intelligence

$161M patent portfolio · 93 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$161M

59.2% of market cap · 2.3× smaller than top peer Translate Bio ($371M)

93 active patent families

Where I-Mab Biopharma innovates Molecular biologyAntiendomysial antibodiesAnti antibodyPharmaceutical drugL1

Below peer median on Legal, Market

Quality vs same-sector peers

I-Mab Biopharma on the five Patsnap quality dimensions

I-Mab Biopharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where I-Mab Biopharma concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across I-Mab Biopharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See I-Mab Biopharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo